Natera (NTRA) Non-Current Deffered Revenue (2016 - 2026)
Natera's (NTRA) quarterly Non-Current Deffered Revenue came in at $16.1 million in Q2 2026, down 5.44% quarter-over-quarter from $17.0 million in Q1 2026.
Analysis
Natera (NTRA) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends
Natera (NTRA) has reported Non-Current Deffered Revenue for 11 consecutive years, with $16.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deffered Revenue changed N/A year-over-year to $16.1 million; the trailing twelve-month figure through Jun 2026 stood at $16.1 million (changed N/A YoY), and the FY2025 full-year result was $17.1 million, up 1.33% from the prior year.
- Non-Current Deffered Revenue retreated to $16.1 million in Q2 2026 per NTRA's latest filing, from $17.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $21.5 million in Q1 2023 and bottomed at $16.1 million in Q2 2026.
- Historically, Non-Current Deffered Revenue has averaged $19.3 million across 5 years, with a median of $20.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue slipped 13.74% in 2022, then climbed 4.71% in 2023.
- Over 5 years, Non-Current Deffered Revenue stood at $20.0 million in 2022, then fell by 4.36% to $19.1 million in 2023, then decreased by 11.97% to $16.8 million in 2024, then grew by 1.33% to $17.1 million in 2025, then decreased by 5.79% to $16.1 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $16.1 million, $17.0 million, and $17.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 16.07 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 22.08 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 16.19 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 608,000.00 |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.07 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | 17.06 Mn |
| Dec 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 19.13 Mn |
| Sep 30, 2023 | 21.03 Mn |
| Jun 30, 2023 | 21.50 Mn |
| Mar 31, 2023 | 21.51 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.41 Mn |
| Jun 30, 2022 | 20.72 Mn |
| Mar 31, 2022 | 20.54 Mn |
| Dec 31, 2021 | 21.32 Mn |
| Sep 30, 2021 | 22.71 Mn |
| Jun 30, 2021 | 23.56 Mn |
| Mar 31, 2021 | 23.82 Mn |
| Dec 31, 2020 | 22.81 Mn |
| Sep 30, 2020 | 23.13 Mn |
| Jun 30, 2020 | 22.53 Mn |
| Mar 31, 2020 | 25.15 Mn |